Psilocybin, the main psychoactive ingredient in magic mushrooms, can alleviate depression for at least five years after a ...

In a phase 2 trial, about half of cancer patients reported sustained reductions in depression and anxiety 2 years after a ...

A single dose of psilocybin provided sustained reductions in depression and anxiety among cancer patients diagnosed with ...

New results from a clinical trial reveal that a single dose of psilocybin—a naturally occurring psychedelic compound found in ...

The psilocybin found in "magic mushrooms" might be key to quelling depression among people battling cancer, a new study found ...

Electroconvulsive therapy (ECT) lowered the risk of death by suicide 34% among patients with severe depression, according to ...

A novel study aimed at disentangling the neurological underpinnings of depression shows that multiple brain profiles may ...

A biotech company founded in Wales last year has raised $140mn in its first financing round to develop drugs for severe ...

Fremanezumab vs placebo significantly reduced monthly migraine days and depressive symptoms in patients with migraine and comorbid major depressive disorder.

Major depressive disorder (MDD) is a mental health condition that negatively affects the mood of a person and causes a loss ...

New results from a clinical trial published by Wiley online in CANCER reveal that a single dose of psilocybin can provide sustained reductions in depression and anxiety in individuals with cancer ...